Hannah H. Chang
Hannah Chang is a managing director at Wu Capital. She focuses on early-stage biopharmaceutical investments out of the firm’s San Francisco office which she leads. Representative investments include Semma Therapeutics (acquired by Vertex Pharmaceuticals), Akouos (Nasdaq: AKUS), PACT Pharma and Gemini Therapeutics.
She was previously an investme...
Roles at Korro Bio